Business Context and Reporting Period
This Form 6-K filing by Nano Dimension Ltd. covers the month of July 2020, specifically reporting on the results of the Annual and Extraordinary General Meeting of Shareholders held on July 7, 2020. The Company is a foreign private issuer based in Ness Ziona, Israel.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document references the discussion of financial statements for the fiscal year ended December 31, 2019, but does not include the numerical data within this report.
Material Changes and Corporate Actions
- Share Capital: Shareholders approved an increase in registered share capital and an amendment to the Articles of Association to reflect a one-for-50 reverse split of ordinary shares, which was effected on June 29, 2020.
- Accounting Firm: Shareholders approved the appointment of Somekh Chaikin (KPMG International) as the independent registered public accounting firm for the year ending December 31, 2020.
- Shareholders Rights Plan: Proposal No. 3 regarding an amendment to the Articles of Association with respect to a shareholders rights plan was not approved by shareholders.
- Compensation and Equity: Shareholders approved amendments to the compensation policy, specific compensation terms for the President and CEO, an investment by the CEO in a warrant transaction, and a grant of options to directors.
Management Commentary and Risks
The meeting was initially adjourned for one and a half hours due to a lack of quorum but was successfully re-convened. Management commentary is limited to the procedural outcomes of the shareholder vote. No specific risks, contingencies, or unusual items were detailed in this filing text.
Key Facts for Investor Verification
- Verify the impact of the one-for-50 reverse split on share count and trading price.
- Confirm the rejection of the shareholders rights plan (Proposal No. 3) and its implications for corporate governance.
- Review the full financial statements for the fiscal year ended December 31, 2019, as referenced but not included in this filing.
- Examine the specific terms of the CEO's warrant transaction and director option grants approved at the meeting.